RGAGX
Price
$86.97
Change
+$0.48 (+0.55%)
Updated
Sep 8 closing price
Net Assets
332.38B
USLCX
Price
$45.02
Change
+$0.19 (+0.42%)
Updated
Sep 8 closing price
Net Assets
2.04B
Interact to see
Advertisement

RGAGX vs USLCX

Header iconRGAGX vs USLCX Comparison
Open Charts RGAGX vs USLCXBanner chart's image
American Funds Growth Fund of Amer R6
Price$86.97
Change+$0.48 (+0.55%)
VolumeN/A
Net Assets332.38B
JHancock U.S. Global Leaders Growth C
Price$45.02
Change+$0.19 (+0.42%)
VolumeN/A
Net Assets2.04B
RGAGX vs USLCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RGAGX vs. USLCX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAGX is a Buy and USLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 332B vs. USLCX (2.04B). RGAGX pays higher dividends than USLCX: RGAGX (0.59) vs USLCX (0.00). RGAGX was incepted earlier than USLCX: RGAGX (16 years) vs USLCX (23 years). USLCX (1.89) is less costly to investors than RGAGX (0.30). USLCX is a more actively managed with annual turnover of: 29.00 vs. RGAGX (25.00). RGAGX has a lower initial minimum investment than USLCX: RGAGX (250) vs USLCX (1000). RGAGX annual gain was more profitable for investors over the last year : 22.13 vs. USLCX (-12.14). RGAGX return over 5 years is better than : 46.68 vs. USLCX (-11.34).
RGAGXUSLCXRGAGX / USLCX
Total Expense Ratio0.301.8816%
Annual Report Gross Expense Ratio0.301.8916%
Fund Existence16 years23 years-
Gain YTD16.6602.505665%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets332B2.04B16,282%
Annual Yield % from dividends0.590.00-
Returns for 1 year22.13-12.14-182%
Returns for 3 years54.3015.64347%
Returns for 5 years46.68-11.34-412%
Returns for 10 years103.9823.72438%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOBX1.120.06
+5.66%
Mobix Labs
VSTA4.560.02
+0.44%
Vasta Platform Limited
TDACU10.40N/A
N/A
Translational Development Acquisition Corp
GRFS10.11-0.02
-0.20%
Grifols SA
BCRX8.19-0.08
-0.97%
BioCryst Pharmaceuticals